Thursday, September 27, 2012
Publication and contact
Multiple myeloma (MM)
Insulin-like growth factor-1 receptor (IGF1R;
growth factor-1 (IGF-1)
In vitro and mouse studies suggest antagonizing IGF1R could
help prevent resistance to Velcade
in patients with MM. In bortezomib-resistant MM cells, secretion of IGF-1 and
activation of IGF1R were greater than those in bortezomib-sensitive cells. In
MM cells, small hairpin RNA against IGF1R increased sensitivity to bortezomib
compared with scrambled shRNA. In MM cells and in mouse xenograft models of
bortezomib-resistant MM, an IGF1R and insulin receptor inhibitor increased
the antiproliferative and tumor-suppressive effects of bortezomib compared with
bortezomib alone. Next steps could include testing the combination in
additional models of MM.
At least 14 companies have IGF1R antagonists or antibodies in development
stages ranging from preclinical to marketed to treat various indications.
Pharmaceutical Co. Ltd. and Johnson
& Johnson market Velcade, a small molecule dipeptide
boronic acid proteasome
inhibitor, to treat MM and mantle cell lymphoma (MCL).
Published online Sept. 27, 2012
Patent and licensing status
Kuhn, D.J. et al. Blood;
Aug. 29, 2012;
Contact: Robert Z. Orlowski, The University of Texas MD
Anderson Cancer Center, Houston, Texas
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]